Ali Chour, Anne-Claire Toffart, Elodie Berton, Michaël Duruisseaux. Mechanisms of resistance to KRASG12C inhibitors in KRASG12C-mutated non-small cell lung cancer. Frontiers in Oncology, 2024, 14, ⟨10.3389/fonc.2024.1328728⟩. ⟨hal-04728393⟩

Anne-Laure Désage, Michaël Duruisseaux, Claire Lafitte, Sophie Bayle-Bleuez, Christos Chouaid, et al.. Toxicities associated with sequential or combined use of immune checkpoint inhibitors and small targeted therapies in non-small cell lung cancer: A critical review of the literature. Cancer Treatment Reviews, 2024, 129, ⟨10.1016/j.ctrv.2024.102805⟩. ⟨hal-04728403⟩

Oliver Illini, Felix Carl Saalfeld, Petros Christopoulos, Michaël Duruisseaux, Anders Vikström, et al.. Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis. International Journal of Molecular Sciences, 2024, 25, ⟨10.3390/ijms25073992⟩. ⟨hal-04728435⟩

Hippolyte Darré, Perrine Masson, Arnaud Nativel, Laura Villain, Diane Lefaudeux, et al.. Comparing the Efficacy of Two Generations of EGFR-TKIs: An Integrated Drug–Disease Mechanistic Model Approach in EGFR-Mutated Lung Adenocarcinoma. Biomedicines, 2024, 12, ⟨10.3390/biomedicines12030704⟩. ⟨hal-04728446⟩

Marco Tagliamento, Marie Morfouace, Charalambos Loizides, Julio Oliveira, Laurent Greillier, et al.. EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers. npj Precision Oncology, 2024, 8, ⟨10.1038/s41698-024-00518-9⟩. ⟨hal-04728457⟩

Manon Gouez, Amélie Rébillard, Amandine Thomas, Sabine Beaumel, Eva-Laure Matera, et al.. Combined effects of exercise and immuno-chemotherapy treatments on tumor growth in MC38 colorectal cancer-bearing mice. Frontiers in Immunology, 2024, 15, pp.1368550. ⟨10.3389/fimmu.2024.1368550⟩. ⟨hal-04479752⟩